Riverside Partners Rebrands as RS2 Healthcare Partners

Boston, MA, May 7, 2026 - Riverside Partners, a Boston-based private equity firm, today announced its rebrand to RS2 Healthcare Partners (the "Firm"), reflecting the Firm's exclusive focus on healthcare investing in the lower middle market.

RS2 Healthcare Partners builds on more than 30 years of experience and formalizes the Firm's strategic decision to exclusively pursue investments with a healthcare orientation going forward. The Firm will continue to focus on pharma services, medical device contract manufacturing, and technology-enabled healthcare, among other high-growth healthcare subsectors.

RS2 Healthcare Partners' specialized strategy is supported by a highly experienced team of investment professionals alongside Healthcare, Clinical, and AI Advisory Boards comprising over 30 executives, clinicians, and technology experts from leading healthcare organizations.

David Belluck, Co-Managing Partner at RS2 Healthcare Partners, said, "RS2 Healthcare Partners reflects the investment strategy and sector specialization we have cultivated over three decades of focused lower middle market healthcare investing. Our dedicated healthcare platform - anchored by established industry relationships, an experienced investment team, and veteran Advisory Boards - creates a differentiated ability to partner with founders and management teams to build market-leading businesses. The rebrand reinforces our commitment to being the partner of choice to founders and management teams in the lower middle market and marks an important milestone in the evolution of our firm."

In addition to the rebrand, RS2 Healthcare Partners also announced the appointment of Craig Stern as Co-Managing Partner, joining David Belluck in leading RS2 Healthcare Partners. Mr. Stern has worked alongside Mr. Belluck for 14 years with an exclusive focus on healthcare investing. His appointment reflects both the depth of their partnership and the Firm's dedication to building a world-class healthcare-focused investment platform.

Mr. Belluck states, "I am pleased to announce Craig Stern's appointment as Co-Managing Partner. Craig and I have worked side by side to build our healthcare investment platform, and his elevated role is a natural next step that is a testament to both the strength of our partnership and our shared commitment to the Firm's continued growth."

"We have been focused on creating a firm with a differentiated approach to healthcare investing, grounded in extensive sector expertise, a collaborative and values-driven culture, and trusted partnerships with founders and management teams," said Craig Stern, Co-Managing Partner at RS2 Healthcare Partners. "We have deep conviction and a shared vision for the opportunity ahead and I am excited to co-lead the Firm going forward with David as we build on the strong foundation already in place."

About RS2 Healthcare Partners

Founded in 1989, RS2 Healthcare Partners (formerly Riverside Partners) is a Boston-based private equity firm with total capital commitments of $1.6 billion raised since inception. The Firm exclusively focuses on healthcare investing in the lower middle market. RS2 Healthcare Partners combines a disciplined investment strategy, specialized sector expertise, a highly experienced team of investment professionals and advisors, and a collaborative approach to partnering with founders and management teams. For more information, visit www.rs2healthcare.com.